|
VANCOUVER, BRITISH COLUMBIA--(Marketwired - July 19, 2013) - RepliCel Life Sciences Inc. (the "Company" or "RepliCel") (OTCBB:REPCF)(CNSX:RP) is pleased to announce the closing of a private placement financing (the "Financing"), pursuant to which it has issued 1,050,000 shares at a price of CAD$0.50 per share for gross proceeds of CAD$525,000. |
